DS-8201a in Human Epidermal Growth Factor Receptor2 (HER2)-Expressing Colorectal Cancer (DESTINY-CRC01)
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Daiichi Sankyo
Related studies linked through entity extraction aliases.
DS-9231 in Intermediate-risk (Sub-massive) Acute Pulmonary Embolism (PE)
- Status
- WITHDRAWN
- Phase
- PHASE2
DS2330b Alone and With Sevelamer in Patients on Chronic Hemodialysis
- Status
- COMPLETED
- Phase
- PHASE1
CRUSHed vs. Uncrushed Prasugrel in STEMI Patients Undergoing PCI
- Status
- COMPLETED
- Phase
- PHASE4
Effect of Pexidartinib on the Way the Body Processes CYP3A4 and CYP2C9 Substrates (Pharmacokinetics)
- Status
- COMPLETED
- Phase
- PHASE1
Evolution of the Therapeutic Care in Metastatic Breast Cancer From 2008
- Status
- RECRUITING
- Phase
- N/A
U3-1402 in Metastatic or Unresectable Non-Small Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
DS-1205c With Osimertinib for Metastatic or Unresectable Epidermal Growth Factor Receptor (EGFR)-Mutant Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1
A Study of DS-8201a in Metastatic Breast Cancer Previously Treated With Trastuzumab Emtansine (T-DM1)
- Status
- TERMINATED
- Phase
- PHASE2
Comparison Between Optimal Coherence Tomography Guidance and Angiography Guidance in Percutaneous Coronary Intervention
- Status
- UNKNOWN
- Phase
- NA
Oral Anticoagulant Peri-procedural Management in Patients Undergoing an Oral Surgery, Implantology or Periodontology
- Status
- TERMINATED
- Phase
- N/A
Effect of Probenecid on Pexidartinib Pharmacokinetics
- Status
- COMPLETED
- Phase
- PHASE1
DS-3201b for Acute Myelogenous Leukemia (AML) or Acute Lymphocytic Leukemia (ALL)
- Status
- TERMINATED
- Phase
- PHASE1
A Pilot Study of Edoxaban in Patients With Non-Valvular Atrial Fibrillation and Left Atrial Appendage Closure
- Status
- UNKNOWN
- Phase
- PHASE4
WAMIF : Young Women Presenting Acute Myocardial Infarction in France
- Status
- COMPLETED
- Phase
- NA
Long Term Assessment of Post Thrombotic Syndrome : OPTIMEV Study ( SPOT )
- Status
- COMPLETED
- Phase
- N/A
Investigation of Exercise Training-Induced Myokines and Adipolkines in Humans
- Status
- COMPLETED
- Phase
- NA
Study of DS-1001b in Patients With Gene IDH1-Mutated Gliomas
- Status
- COMPLETED
- Phase
- PHASE1
Antibody DS-8273a Administered in Combination With Nivolumab in Subjects With Advanced Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Phase 2 Study of Quizartinib in Participants With Acute Myeloid Leukemia (AML) FLT3 Internal Tandem Duplication (FLT3/ITD) Mutation
- Status
- COMPLETED
- Phase
- PHASE2